Divisekera U - Search Results

1

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis.

Stagg J, Divisekera U, McLaughlin N, Sharkey J, Pommey S, Denoyer D, Dwyer KM, Smyth MJ. Stagg J, et al. Among authors: divisekera u. Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1547-52. doi: 10.1073/pnas.0908801107. Epub 2010 Jan 4. Proc Natl Acad Sci U S A. 2010. PMID: 20080644 Free PMC article.

2

CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis.

Stagg J, Divisekera U, Duret H, Sparwasser T, Teng MW, Darcy PK, Smyth MJ. Stagg J, et al. Among authors: divisekera u. Cancer Res. 2011 Apr 15;71(8):2892-900. doi: 10.1158/0008-5472.CAN-10-4246. Epub 2011 Feb 3. Cancer Res. 2011. PMID: 21292811

3

Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy.

Stagg J, Loi S, Divisekera U, Ngiow SF, Duret H, Yagita H, Teng MW, Smyth MJ. Stagg J, et al. Among authors: divisekera u. Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7142-7. doi: 10.1073/pnas.1016569108. Epub 2011 Apr 11. Proc Natl Acad Sci U S A. 2011. PMID: 21482773 Free PMC article.

4

CD73-deficient mice are resistant to carcinogenesis.

Stagg J, Beavis PA, Divisekera U, Liu MC, Möller A, Darcy PK, Smyth MJ. Stagg J, et al. Among authors: divisekera u. Cancer Res. 2012 May 1;72(9):2190-6. doi: 10.1158/0008-5472.CAN-12-0420. Epub 2012 Mar 6. Cancer Res. 2012. PMID: 22396496

5

Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors.

Beavis PA, Divisekera U, Paget C, Chow MT, John LB, Devaud C, Dwyer K, Stagg J, Smyth MJ, Darcy PK. Beavis PA, et al. Among authors: divisekera u. Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14711-6. doi: 10.1073/pnas.1308209110. Epub 2013 Aug 20. Proc Natl Acad Sci U S A. 2013. PMID: 23964122 Free PMC article.

6

Modifications and intracellular trafficking of FADD/MORT1 and caspase-8 after stimulation of T lymphocytes.

O'Reilly LA, Divisekera U, Newton K, Scalzo K, Kataoka T, Puthalakath H, Ito M, Huang DC, Strasser A. O'Reilly LA, et al. Among authors: divisekera u. Cell Death Differ. 2004 Jul;11(7):724-36. doi: 10.1038/sj.cdd.4401408. Cell Death Differ. 2004. PMID: 15017386

7

Biological stability and activity of siRNA in ionic liquids.

Mazid RR, Divisekera U, Yang W, Ranganathan V, MacFarlane DR, Cortez-Jugo C, Cheng W. Mazid RR, et al. Among authors: divisekera u. Chem Commun (Camb). 2014 Nov 14;50(88):13457-60. doi: 10.1039/c4cc05086j. Chem Commun (Camb). 2014. PMID: 25232641

8

Immobilization and surface characterization of NeutrAvidin biotin-binding protein on different hydrogel interlayers.

Vermette P, Gengenbach T, Divisekera U, Kambouris PA, Griesser HJ, Meagher L. Vermette P, et al. Among authors: divisekera u. J Colloid Interface Sci. 2003 Mar 1;259(1):13-26. doi: 10.1016/s0021-9797(02)00185-6. J Colloid Interface Sci. 2003. PMID: 12651129

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters